Prime Medicine, Inc. (PRME)
3.89
-0.41
(-9.53%)
USD |
NASDAQ |
Nov 10, 16:00
3.755
-0.14
(-3.47%)
After-Hours: 20:00
Prime Medicine Cash from Operations (Annual) : -162.56M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -162.56M |
| December 31, 2024 | -122.86M |
| December 31, 2023 | -165.41M |
| December 31, 2022 | -131.83M |
| Date | Value |
|---|---|
| December 31, 2021 | -34.08M |
| December 31, 2020 | -5.544M |
| December 31, 2019 | -1.334M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Intellia Therapeutics, Inc. | -394.74M |
| Beam Therapeutics, Inc. | -345.10M |
| Twist Bioscience Corp. | -47.63M |
| Moderna, Inc. | -1.873B |
| Q32 Bio, Inc. | -33.54M |